| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
CareAllies works side-by-side with health care providers to help improve the quality, value and experience of care for their patients, to make health care better for everyone. Our aim: To support doctor-patient-community engagement that enhances the quality and affordability of care. It`s how physicians and health systems will deliver sustainable value-based care and continue to thrive in the future.
Cardinal Fitness is a Merrillville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ga Assoc For Primary Health Care is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DTx Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Melbourne, FL. To find more information about DTx Inc., please visit www.dtx.com.